Showing results (251-260 of 308) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|September 27, 2025
Development of a Competency Framework for Medical Affairs Professionals in AustralasiaAndrew Weekes, Matthew Britland, Cathey Saha, et al.Pharmaceutical Medicine|July 12, 2025
Pioneering the Future of Medical Affairs: A Strategic Transformation to Meet the Spanish Healthcare Ecosystem's Evolving TrendsAna Pérez Domínguez, Jorge Marinich, Gema Monteagudo, et al.Pharmaceutical Medicine|July 16, 2025
Treatment Persistence in Rheumatoid Arthritis Before and After Etanercept Biosimilar Introduction: A Nationwide Australian Real-World StudyChin Hang Yiu, Bella D Ianni, Richard O Day, et al.Pharmaceutical Medicine|April 11, 2025
Cost and Duration of Clinical Trials in Drug Development by Japanese Pharmaceutical CompaniesNorihiro Okada, Yosuke TakahashiPharmaceutical Medicine|May 14, 2025
Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative ReviewAnna Amela Valsecchi, Massimo Di MaioPharmaceutical Medicine|September 20, 2025
The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022Yazeed Ghawaa, Alex C Lin, Jeff Jianfei GuoPharmaceutical Medicine|August 8, 2025
A Framework for Considering the Role of the Public Sector in R&D of Health TechnologyJuan Carlos Rejon-Parrilla, David Epstein, Jorge Mestre-Ferrandiz, et al.Pharmaceutical Medicine|September 19, 2025
Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) AssessmentsKanoko Goto, Aya Hariu, Ryosuke KuribayashiPharmaceutical Medicine|December 5, 2017
Medicines Regulation in Africa: Current State and OpportunitiesMargareth Ndomondo-Sigonda, Jacqueline Miot, Shan Naidoo, et al.Pharmaceutical Medicine|October 24, 2017
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified RisksMakoto Fujikawa, Shunsuke OnoPageof 31